skip to main content

Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by rebiject autoinjection over a 1-year period

Lugaresi, Alessandra

[Milano] : Wolters Kluwer Health ; [S.l.] : Lippincott Williams & Wilkins, 2008. - P. 167-172 ; 28 cm

Risorsa analogica

  • Titolo:
    Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by rebiject autoinjection over a 1-year period
  • Autore: Lugaresi, Alessandra
  • Editore: Wolters Kluwer Italia
  • Classe: ALTRE MALATTIE ORGANICHE DEL SISTEMA NERVOSO CENTRALE. SCLEROSI MULTIPLA. FARMACOTERAPIA (616.834061, DDC 21)
  • Soggetti: SCLEROSI MULTIPLA - FARMACOTERAPIA
  • Descrizione: Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by rebiject autoinjection over a 1-year period : the cosa study / Alessandra Lugaresi ... [et al.]. - [Milano] : Wolters Kluwer Health ; [S.l.] : Lippincott Williams & Wilkins, 2008. - P. 167-172 ; 28 cm. ((Estratto da: Clinical neuropharmacology, v. 31, n. 3 (mag.-giu. 2008).
  • Localizzazione: APE-M F20 3052

Ricerca in corso nelle risorse remote ...